Cytek Biosciences, Inc.·4

Jun 3, 5:39 PM ET

McCombe William D. 4

4 · Cytek Biosciences, Inc. · Filed Jun 3, 2025

Insider Transaction Report

Form 4
Period: 2025-06-02
McCombe William D.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-06-02$2.78/sh+35,000$97,30055,746 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.76 to $2.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file
  • 4
    form4-06032025_090608.xmlPrimary